Cite
[A Case of Stage Ⅳc dMMR Transverse Colon Cancer with Complete Response to Combination Therapy with Immune Checkpoint Inhibitor in Stage ⅣB Lung Adenocarcinoma].
MLA
Kageyama, Chiyuki, et al. “[A Case of Stage Ⅳc DMMR Transverse Colon Cancer with Complete Response to Combination Therapy with Immune Checkpoint Inhibitor in Stage ⅣB Lung Adenocarcinoma].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 50, no. 10, Oct. 2023, pp. 1114–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=38035848&authtype=sso&custid=ns315887.
APA
Kageyama, C., Yoshimatsu, K., Tanaka, H., Higashida, M., Ito, Y., Okada, T., Endo, S., Fujiwara, Y., & Ueno, T. (2023). [A Case of Stage Ⅳc dMMR Transverse Colon Cancer with Complete Response to Combination Therapy with Immune Checkpoint Inhibitor in Stage ⅣB Lung Adenocarcinoma]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 50(10), 1114–1116.
Chicago
Kageyama, Chiyuki, Kazuhiko Yoshimatsu, Hironori Tanaka, Masaharu Higashida, Yoshitomo Ito, Toshimasa Okada, Shunji Endo, Yoshinori Fujiwara, and Tomio Ueno. 2023. “[A Case of Stage Ⅳc DMMR Transverse Colon Cancer with Complete Response to Combination Therapy with Immune Checkpoint Inhibitor in Stage ⅣB Lung Adenocarcinoma].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 50 (10): 1114–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=38035848&authtype=sso&custid=ns315887.